Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolonged Hypercoagulability Following Major Liver Resection for Malignancy

NCT06153394 is registered in ClinicalTrials.gov with Western University, Canada as lead sponsor.

NCT NCT06153394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06153394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
Lead sponsor
Western University, Canada
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 1, 2024
Completion date
February 1, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic disease, hypercoagulability, surgery-complications, thrombosis